Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 87,400 shares at $272.46 ($23.6M) on 2020-05-07, disclosed to the SEC on 2020-05-08.
Open-market sale of $23.6M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $267.50 | 2,600 | $696K | 2.9% |
| 2 | $268.65 | 11,568 | $3.1M | 13.2% |
| 3 | $268.65 | 11,568 | $3.1M | 13.2% |
| 4 | $269.53 | 15,751 | $4.2M | 18.0% |
| 5 | $269.53 | 15,751 | $4.2M | 18.0% |
| 6 | $270.49 | 5,889 |
| $1.6M |
| 6.8% |
| 7 | $270.49 | 5,889 | $1.6M | 6.8% |
| 8 | $271.63 | 6,232 | $1.7M | 7.2% |
| 9 | $271.63 | 6,232 | $1.7M | 7.2% |
| 10 | $272.46 | 2,960 | $806K | 3.4% |
| 11 | $272.46 | 2,960 | $806K | 3.4% |
| Total | $269.86 avg | 87,400 | $23.6M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |